SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status
Ayad Al‐Katib(Wayne State University), Ramzi M. Mohammad(Wayne State University)
Cited by 32
Related Papers
Anticancer Activity of Camel Milk via Induction of Autophagic Death in Human Colorectal and Breast Cancer Cells
|Asian Pacific Journal of Cancer Prevention|2018|64
HDM2 antagonist MI-219 (spiro-oxindole), but not Nutlin-3 (cis-imidazoline), regulates p53 through enhanced HDM2 autoubiquitination and degradation in human malignant B-cell lymphomas
|Journal of Hematology & Oncology|2012|37
Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition
|Scientific Reports|2015|36